BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7521856)

  • 1. Lack of effect of transdermal estrogen on the growth hormone-insulin-like growth factor axis.
    Dall'Aglio E; Valenti G; Hoffman AR; Zuccarelli A; Passeri M; Ceda GP
    Horm Metab Res; 1994 Apr; 26(4):211-2. PubMed ID: 7521856
    [No Abstract]   [Full Text] [Related]  

  • 2. Progestins abrogate estrogen-induced changes in the insulin-like growth factor axis.
    Heald A; Selby PL; White A; Gibson JM
    Am J Obstet Gynecol; 2000 Sep; 183(3):593-600. PubMed ID: 10992179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
    Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
    Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-insulin-like growth factor axis and colon cancer.
    Sridhar SS; Goodwin PJ
    J Clin Oncol; 2009 Jan; 27(2):165-7. PubMed ID: 19064959
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis.
    Kratzsch J; Blum WF; Schenker E; Keller E
    Exp Clin Endocrinol Diabetes; 1995; 103(5):285-91. PubMed ID: 8536056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight secretion pattern of growth hormone, sex hormone binding globulin, insulin-like growth factor-1 and its binding protein in obese and non-obese women with polycystic ovarian disease.
    Insler V; Barash A; Shoham Z; Koistinen R; Seppala M; Hen M; Lunenfeld B; Zadik Z
    Isr J Med Sci; 1994 Jan; 30(1):42-7. PubMed ID: 7511134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF binding proteins and their functions.
    Clemmons DR
    Mol Reprod Dev; 1993 Aug; 35(4):368-74; discussion 374-5. PubMed ID: 7691098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers.
    Decensi A; Bonanni B; Baglietto L; Guerrieri-Gonzaga A; Ramazzotto F; Johansson H; Robertson C; Marinucci I; Mariette F; Sandri MT; Daldoss C; Bianco V; Buttarelli M; Cazzaniga M; Franchi D; Cassano E; Omodei U
    Clin Cancer Res; 2004 Jul; 10(13):4389-97. PubMed ID: 15240527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor 1 and its binding protein 1 during normal and diabetic pregnancies.
    Whittaker PG; Stewart MO; Taylor A; Howell RJ; Lind T
    Obstet Gynecol; 1990 Aug; 76(2):223-9. PubMed ID: 1695341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine events prior to puberty in heifers: role of somatotropin, insulin-like growth factor-I and insulin-like growth factor binding proteins.
    Armstrong JD; Stanko RL; Cohick WS; Simpson RB; Harvey RW; Huff BG; Clemmons DR; Whitacre MD; Campbell RM; Heimer EP
    J Physiol Pharmacol; 1992 Dec; 43(4 Suppl 1):179-93. PubMed ID: 1285340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy.
    Raudaskoski T; Knip M; Laatikainen T
    Menopause; 1998; 5(4):217-22. PubMed ID: 9872487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
    Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease.
    Fischer F; Schulte H; Mohan S; Tataru MC; Köhler E; Assmann G; von Eckardstein A
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):595-602. PubMed ID: 15521962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasma insulin-like growth factor 1 carrier protein in vivo.
    Ryan J; Mantle T; Costigan DC
    Biochem Soc Trans; 1990 Apr; 18(2):335-6. PubMed ID: 1696226
    [No Abstract]   [Full Text] [Related]  

  • 17. The growth hormone dependence of a somatomedin-binding protein in human serum.
    White RM; Nissley SP; Moses AC; Rechler MM; Johnsonbaugh RE
    J Clin Endocrinol Metab; 1981 Jul; 53(1):49-57. PubMed ID: 6165734
    [No Abstract]   [Full Text] [Related]  

  • 18. Preservation of inherent diurnal serum insulin-like growth factor binding protein 1 pattern during low dose GH infusion.
    Jørgensen JO; Møller N; Bang P; Hall K
    Horm Metab Res; 1992 Oct; 24(10):496-7. PubMed ID: 1281460
    [No Abstract]   [Full Text] [Related]  

  • 19. An assessment of growth hormone provocation tests.
    Hindmarsh PC; Swift PG
    Arch Dis Child; 1995 Apr; 72(4):362-7; discussion 367-8. PubMed ID: 7539245
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited.
    Rosenfeld RG; Albertsson-Wikland K; Cassorla F; Frasier SD; Hasegawa Y; Hintz RL; Lafranchi S; Lippe B; Loriaux L; Melmed S
    J Clin Endocrinol Metab; 1995 May; 80(5):1532-40. PubMed ID: 7538145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.